Status:
RECRUITING
Effects of an ACT-based Psychological Treatment in Patients With Chronic Kidney Disease
Lead Sponsor:
Universidad Europea de Madrid
Collaborating Sponsors:
Fundación Renal Iñigo Alvarez De Toledo
Centro de Enseñanza Superior Cardenal Cisneros
Conditions:
Chronic Kidney Diseases
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Investigation of the efficacy of Acceptance and Commitment Therapy (ACT) for the psychological treatment of patients with chronic kidney disease.
Detailed Description
After being informed about the study, all patients giving written informed consent will be assessed to determine eligibility for study entry. The clinical trial will include a control group (waiting ...
Eligibility Criteria
Inclusion
- Patients with chronic kidney disease on haemodialysis
- Older than 18 years-old
- At least 3 months on haemodialysis
- HADS Global Scale Score ≥14
Exclusion
- Diagnosis of severe or chronic mental disorder, mental retardation and cognitive impairment, or disabling illness.
- Antidepressant drugs consume
- Insufficient understanding of Spanish.
- Patients who are in the Advanced Chronic Kidney Disease Unit
- Receiving other psychological treatment
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT06109493
Start Date
November 1 2023
End Date
June 30 2026
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación Renal Iñigo Alvarez de Toledo
Madrid, Spain, 28003